Skip to main content

Human Genome Sciences Appoints New Head of Business Development

NEW YORK, Aug 15 – In a move signaling Human Genome Sciences’ intentions to expand its business, the company has appointed Ellen Baron to the position of senior vice president, business development.

In her new role, Baron, who was previously senior director of business development at Schering-Plough, will be responsible for licensing products and technologies as well as for carrying out possible mergers and acquisitions.

Baron will report directly to William Haseltine, the Human Genome Sciences’ CEO.

"I believe that Human Genome Sciences is at the forefront of the revolutionary dynamics taking place in the practice of medicine through the use of human genomic information, the establishment of biological knowledge and intellectual property and the commercialization of potential gene-based therapeutic and regenerative medicine products,” Baron said in a statement released Tuesday.

In July, Human Genome Sciences announced that it was entering a new phase of its business, following the expiration of a 1996 agreement that gave members of the human gene therapeutic consortium equal access to HGS’s technology and intellectual property for the development of small molecule and antibody drugs. 

After the expiry of the deal, the consortium’s five pharmaceutical members no longer had the right to use Human Genome Sciences' technology for new purposes. As a result, Human Genome Sciences regained exclusive rights to the databases and bioinformatics tools developed through the consortium, allowing the company to pursue new partnerships as well as to expand the business through mergers and acquisitions.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.